Suven Life Sciences Limited

Overview

Suven Life Sciences Limited is a biopharmaceutical company focused on the discovery and development of novel therapeutic agents. They specialize in central nervous system (CNS) disorders such as Alzheimer's, schizophrenia, and depression.

Therapeutic areas

API / Drug Master Files

Suven Life Sciences Limited holds 5 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• LOSARTAN POTASSIUM USPActive2011-02-18
• ZOLMITRIPTANActive2009-10-20
• ARIPIPRAZOLEActive2009-06-01
• CALCIUM ACETATE USPActive2009-04-30
• DIVALPROEX SODIUMActive2006-03-18

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Suven Life Sciences Limited in our records. PharmaTek screens the full directory against live FDA enforcement data.